Research in the Obeng lab centers on the pathogenesis of myeloid malignancies including clonal hematopoiesis (CH), myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). We are investigating how acquired somatic mutations in hematopoietic stem cells lead to clonal expansion and malignant transformation. Mutations in components of the mRNA splicing machinery and epigenetic regulators are common and early events in MDS. The major interests of the Obeng lab are (1) determining how mutations in components of the mRNA spliceosome and epigenetic regulators cooperate to cause clonal hematopoiesis and leukemia (2) identifying and studying novel treatments that selectively target mutant stem cells and (3) determining the incidence and clinical significance of clonal hematopoiesis of indeterminate potential (CHIP) in pediatric cancer survivors. ADDITIONAL JOB DETAILS: We are seeking a highly motivated individual with an interest in biomedical research. The ideal applicant will utilize state-of-the-art techniques in genetics, molecular biology, and cell biology to characterize in vitro and in vivo models of human diseases with a particular focus upon RNA splicing factor mutations and their relationship to MDS and leukemia. You will have the opportunity to develop and lead projects using several cutting-edge model systems including isogenic immortalized cell lines generated using CRISPR-Cas9 gene editing, novel xenograft and transgenic in vivo systems, and primary patient samples. In this position, you will gain extensive experience and training in genomics, stem cell biology, and pre-clinical study development. Successful applicants will have an interest in basic and translational research and respond well to a busy and dynamic lab environment.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Number of Employees
5,001-10,000 employees